$988 million is a large hole to find in a business that generated $2.5 billion of revenue. Concentrix's nine-month net loss reached $988.1 million, while a non-cash goodwill impairment was the primary reason operating income turned into a loss rather than a comparable drain on the company's bank account.
That distinction matters because the operating business barely moved on the top line. Revenue slipped 1.2% from the comparable nine-month period, gross margin edged up to 34.6%, and operating cash flow fell 4.3% to $442.9 million. The income statement shows a far larger change than the cash-flow statement, which reflected $442.9 million of operating cash inflow rather than a billion-dollar cash outflow.
Management directly tied the collapse in operating income to the impairment:
"Our operating income (loss) decreased during the three and nine months ended August 31, 2026, compared to the three and nine months ended August 31, 2025, primarily due to the non-cash goodwill impairment charge."
Concentrix, Form 10-Q, October 7, 2026
Operating income went from $147.0 million to a $910.3 million loss, taking operating margin from 5.9% to negative 37.1%. The charge changes the reported earnings picture far more than it changes the cash economics of the nine months.
The less dramatic numbers still carry their own message. Cash fell 30.1% to $244.7 million, while accounts receivable declined 4.0% to $2.0 billion. Capex also fell 13.1% to $149.1 million, and the company said that reduction helped lift free cash flow even as operating cash generation weakened.
That is the filing's central tension: Concentrix is not showing revenue growth, but neither is it showing a matching collapse in gross margin or operating cash flow. At the same time, the balance sheet remains a substantial part of the picture. The company carries $4.2 billion of net debt on the latest annual figures, against a $1.6 billion market value, so a non-cash impairment can be an accounting mark while still putting a spotlight on the assets and financing structure at issue.
The company also said lower debt outstanding reduced interest expense during the latest period. The lower expense affected results below operating income, while revenue was still down 1.2%. Diluted shares fell 2.9% to 60.9 million, another change that affects per-share arithmetic without explaining the operating loss.
Concentrix's own annual record adds some scale. Revenue rose from $4.7B in 2019 to $9.8B in 2025, but annual operating margin moved from 6.3% to negative 9.3%. The latest nine-month filing extends that margin pressure, while the goodwill charge makes the newest loss look much larger than the cash result alone.
The next filing will give readers another comparison point: whether operating cash flow remains near the latest nine-month $442.9 million level as revenue remains around $2.5 billion, or whether the non-cash headline is joined by a new cash-flow change.
Source: Concentrix Form 10-Q filed October 7, 2026, covering the nine months ended August 31, 2026.